Trial intelligence / Profile preview

Citalopram and Complicated Grief Therapy for Complicated Grief

NCT01179568Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Mar 2010
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of citalopram in prolonged grief disorder (PGD), sponsored by New York State Psychiatric Institute. Started Mar 2010; status: completed.

02

Drugs

citalopram
03

Conditions

prolonged grief disorder (PGD)

Beyond the preview

Go deeper on NCT01179568.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01179568.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call